SIRT2 and breast carcinoma: NAM doses between 5 and 20 mM are known to induce mitophagy with a mechanism likely related to the NAD+ increase [72]; apoptosis and mitophagy were shown to be SIRT2 dependent in the highly aggressive MDA-MB-231 breast cancer cells [73].